Hadrian Dr. Schepler

Dr. Hadrian Dr. Schepler


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
RSRatnakar Shukla
Ratnakar Shukla
PKPriyanka Karagaiah
Priyanka Karagaiah
APAnant Patil
Anant Patil
KFKatherine Farnbach
Katherine Farnbach
ALAlex Ortega Loayza
Alex Ortega Loayza
Mohamad GoldustMohamad Goldust
Mohamad Goldust
Hidradenitis suppurativa (HS) is a chronic, progressive inflammatory disorder of follicular occlusion with pubertal onset that presents as painful inflammatory nodules, sinus tracts, and tunnelling in apocrine-gland-rich areas, such as the axilla, groin, lower back, and buttocks. The disease course is complicated by contractures, keloids, and immobility and is often associated with a low quality of life. It is considered a disorder of follicular occlusion with secondary inflammation, though the exact cause is not known. Management can often be unsatisfactory and challenging due to the chronic nature of the disease and its adverse impact on the quality of life. A multidisciplinary approach is key to prompt optimal disease control. The early stages can be managed with medical treatment, but the advanced stages most likely require surgical intervention. Various surgical options are available, depending upon disease severity and patient preference. In this review an evidence-based outline of surgical options for the treatment of HS are discussed. Case reports, case series, cohort studies, case-control studies, and Randomized Clinical Trials (RCT)s available in medical databases regarding surgical options used in the treatment of HS were considered for the review presented in a narrative manner in this article.

9 November 2020 in Molecules
Verified
Journal Article
Open access
PDF file
SWshunfeng wang
shunfeng wang
Xiaohong WANGXiaohong WANG
Xiaohong WANG
Meik NeufurthMeik Neufurth
Meik Neufurth
ETEmad Tolba
Emad Tolba
HSHadrian Dr. Schepler
Hadrian Dr. Schepler
Werner E.G. MüllerWerner E.G. Müller
Werner E.G. Müller
In the present study, the fabrication of a biomimetic wound dressing that mimics the extracellular matrix, consisting of a hydrogel matrix composed of non-oxidized and periodate-oxidized marine alginate, was prepared to which gelatin was bound via Schiff base formation. Into this alginate/oxidized-alginate-gelatin hydrogel, polyP was stably but reversibly integrated by ionic cross-linking with Zn2+ ions. Thereby, a soft hybrid material is obtained, consisting of a more rigid alginate scaffold and porous structures formed by the oxidized-alginate-gelatin hydrogel with ionically cross-linked polyP. Two forms of the Zn-polyP-containing matrices were obtained based on the property of polyP to form, at neutral pH, a coacervate—the physiologically active form of the polymer. At alkaline conditions (pH 10), it will form nanoparticles, acting as a depot that is converted at pH 7 into the coacervate phase. Both polyP-containing hydrogels were biologically active and significantly enhanced cell growth/viability and attachment/spreading of human epidermal keratinocytes compared to control hydrogels without any adverse effect on reconstructed human epidermis samples in an in vitro skin irritation test system. From these data, we conclude that polyP-containing alginate/oxidized-alginate-gelatin hydrogels may provide a suitable regeneratively active matrix for wound healing for potential in vivo applications.

1 January 2021 in Theranostics
Verified
Journal Article
Open access
HSHadrian Dr. Schepler
Hadrian Dr. Schepler
Xiaohong WANGXiaohong WANG
Xiaohong WANG
MNMeik Neufurth
Meik Neufurth
SWShunfeng Wang
Shunfeng Wang
Heinz C SchröderHeinz C Schröder
Heinz C Schröder
Werner E.G. MüllerWerner E.G. Müller
Werner E.G. Müller
Rationale: The pandemic caused by the novel coronavirus SARS-CoV-2 is advancing rapidly. In particular, the number of severe courses of the disease is still dramatically high. An efficient drug therapy that helps to improve significantly the fatal combination of damages in the airway epithelia, in the extensive pulmonary microvascularization and finally multiorgan failure, is missing. The physiological, inorganic polymer, polyphosphate (polyP) is a molecule which could prevent the initial phase of the virus life cycle, the attachment of the virus to the target cells, and improve the epithelial integrity as well as the mucus barrier.

29 January 2020 in Dermatologic Therapy
Verified
Journal Article
Closed access
PDF file
Mohamad GoldustMohamad Goldust
Mohamad Goldust
MGMario Giulini
Mario Giulini
BWBeate Weidenthaler‐Barth
Beate Weidenthaler‐Barth
MGMrinal Gupta
Mrinal Gupta
SGStephan Grabbe
Stephan Grabbe
HSHadrian Dr. Schepler
Hadrian Dr. Schepler
Angiosarcomas (AS) are aggressive tumors of vascular endothelial origin, occurring sporadically or in association with prior radiotherapy or chronic lymphedema. With only 1–5% of all sarcomas, the incidence seems low, but for the affected patient due to the extremely poor prognosis and the limited treatment options, the fate is often inevitable. Radiotherapy, chemotherapy or “target therapy” have been used in the management of AS, but represent individual case decisions without lasting evidence. Over the past few years, breast‐conserving surgery followed by radiation therapy, known as breast‐conserving therapy (BCT), is being employed as a standard treatment for early‐stage breast cancer, but there has been an increase in reports of AS following BCT. We report 2 cases of AS following BCT and one case of primary AS involving the lower limb.

14 June 2022
Verified
Book Chapter
Closed access
PDF file
Xiaohong WANGXiaohong WANG
Xiaohong WANG
HSHadrian Dr. Schepler
Hadrian Dr. Schepler
MNMeik Neufurth
Meik Neufurth
SWShunfeng Wang
Shunfeng Wang
Heinz C SchröderHeinz C Schröder
Heinz C Schröder
Werner E.G. MüllerWerner E.G. Müller
Werner E.G. Müller

1 January 2018 in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
Verified
Journal Article
Closed access
PDF file
HSHadrian Dr. Schepler
Hadrian Dr. Schepler